Advanced search
Publication Cover
Clinical and Experimental Hypertension. Part A: Theory and Practice Volume 9, 1987 - Issue 2-3
Journal homepage
10
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Angiotensin Converting Enzyme Inhibition in Plasma and Tissues

C. I. Johnston Melbourne University, Department of Medicine Austin Hospital Heidelberg, Victoria, 3084, Australia
,
R. Cubela Melbourne University, Department of Medicine Austin Hospital Heidelberg, Victoria, 3084, Australia
,
K. Sakaguchi Melbourne University, Department of Medicine Austin Hospital Heidelberg, Victoria, 3084, Australia
&
B. Jackson Melbourne University, Department of Medicine Austin Hospital Heidelberg, Victoria, 3084, Australia
Pages 307-321 | Published online: 03 Jul 2009

References

  • Johnston C. I, Arnolda L., Hiwatari M. Angiotensin converting enzyme inhibitors in the treatment of hypertension. Drugs 1984; 27: 271–277
  • Edwards C. R.W., Padfield P. L. Angiotensin converting enzyzme inhibitors: past, present and bright future. Lancet 1985; 1: 30–34
  • Ondetti M. A, Cushman D. W. Enzymes of the renin angiotensin system and their inhibitors. Ann. Rev. Biochem. 1982; 51: 238–308
  • Johnston C. I. Angiotensin converting enzyme inhibitors. Handbook of Hypertension, Vol 5: Clinical pharmacology of antihypertensive drugs, A. E. Doyle. Elsevier Science Publishers B.V., Amsterdam 1984; 272–311
  • Jackson B., Cubela R., Johnston C. I. Effect of dietary sodium on angiotensin converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK421) in essential hypertension. J. Hypertension 1984; 2: 371–377
  • Johnston C. I, McGrath B. P, Matthews Jackson P. G.B. Treatment of hypertension with angiotensin converting enzyme inhibitors. Clin, and Exp. Pharmacol, and Physiol. 1982, Supp 7: 135–144
  • Cushman D. W, Cheung H. S, Sabo E., Ondetti M. A. Angiotensin converting enzyme inhibitors: evolution of a new class of antihypertensive drug inhibitor. Angiotensin converting enzyme inhibitors: mechanism of action and clinical implications, A. N. Richards. Urban and Schwarzenberg, Baltimore 1981; 3–25
  • Biollaz J., Burnier M., Turini G. A. Three new long acting converting enzyme inhibitors: relationship between plasma converting enzyme activity and response to angiotensin I. Clin. Pharmacol. Ther. 1981; 29: 655–670
  • Hara A., Fukuyama K., Epstein W. L. Angiotensin converting enzymes measured in mouse tissues by inhibition of histidyl-leucine peptidase. Biochem. Med. 1981; 26: 199–210
  • Jackson B., Cubela R., Johnston C. I. Angiotensin converting enzyme (ACE) measurement in human serum using radioinhibitor ligand binding. Aust. J. Exp. Biol. Med. Sci. 1986; 64: 149–155, Pt 2
  • Hunter W. M, Greenwood F. C. Preparation of iodine 131 labelled human growth hormone of high specific activity. Nature 1962; 194: 495–496
  • Cushman D. W, Cheung H. S. Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochem. Pharmacol. 1971; 20: 1637–1648
  • Jackson C. I., Johnston B., Cubela R., Larmour I., Arnolda L. Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitors. J. Cardiovasc. Pharmacol. 1986; 8(Suppl 1)S9–S14
  • Hichens M., Hand E. L, Mulchay N. S. Radioimmuno assay for angiotensin converting enzyme inhibitors. Ligand Quarterly 1981; 4: 43–47
  • Fyhrquist F., Tikkanen I., Gronhagen-Riska C., Hortling L., Hichens M. Inhibitor binding assay for angiotensin converting enzyme. Clin Chem. 1984; 30: 696–700
  • Fyhrquist F., Tikkanen I., Gronhagen-Riska C. Competitive inhibitor binding assay (IBA) of captopril and other inhibitors of angiotensin converting enzyme. Scand. J. Urol. Nephrol. 1984, Suppl 73: 13–16
  • Ulm E. H, Hichens M., Till H. J., Gomez A. E., Hand E., Vassil T. C, Biollaz J., Brunner H. R., Schelling J. L. Enalapril Maleate and Lysine Analogue (MK-521): Disposition in man. Br. J. Clin. Pharmacol. 1982; 14: 357–362
  • Sweet C. S, Phyllis T. A, Arbegast S. L.W.G. Angiotensin I blockade and antihypertensive properties of single doses of MK421 and captopril in spontaneous and renal hypertensive rats. J. Pharmacol. 1981; 76: 167–176
  • Ward P. E, Erdös E. G, Gedney C. D, Dowben R. M, Reynolds R. C. Isolation of membrane bound renal enzymes that metabolise kinins and angiotensins. Biochem J. 1976; 157: 643–650
  • Strittmatter S. M, Lo M. M, Javitch J. A, Snyder S. H. Autoradiographic visualization of (3H) Captopril: localization to the striatonigral pathway. Proc. Natl. Acad. Sci. USA. 1984; 5: 1599–1603

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.